Increases in circulating TNF-α are associated with peripheral insulin resistance, increased plasma glucose and insulin levels before the onset of T2D, whereas the increased fasting glucose level induced by obesity can be prevented by TNF-α deficiency [45]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.